Vimarsana
Biggest News Aggregation in the World

Recursion Data News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Recursion Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Recursion Data Today - Breaking & Trending Today

Sector Update: Health Care Stocks Softer in Afternoon Trading - Vimarsana News

Sector Update: Health Care Stocks Softer in Afternoon Trading

-- Health care stocks were mostly lower on Wednesday afternoon with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund both down 0.1%. The iShares Biotechnology ETF was climbing...

Recursion is Granted EU Orphan Drug Designation for REC-4881 for the Potential Treatment of Familial Adenomatous Polyposis - Vimarsana News

Recursion is Granted EU Orphan Drug Designation for REC-4881 for the Potential Treatment of Familial Adenomatous Polyposis

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Recursion is Granted EU Orphan Drug Designation for REC-4881 for the Potential Treatment of Familial Adenomatous Polyposis - Vimarsana News

Recursion is Granted EU Orphan Drug Designation for REC-4881 for the Potential Treatment of Familial Adenomatous Polyposis

SALT LAKE CITY, July 21, 2022 /PRNewswire/ -- Recursion (NASDAQ: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today announced that the

Recursion to Participate in Upcoming Investor Conferences - Vimarsana News

Recursion to Participate in Upcoming Investor Conferences

/PRNewswire/ -- Recursion (NASDAQ: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today announced its...

Recursion Provides Business Updates and Reports First Quarter 2022 Financial Results - Vimarsana News

Recursion Provides Business Updates and Reports First Quarter 2022 Financial Results

/PRNewswire/ -- Recursion (Nasdaq: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today reported business...